Iskra Medical, D.O.O.

Iskra Medical specializes in infrared imaging devices. Specifically, they produce the ISKRA MEDICAL GREEN IRF PRESTIGE, which is designed for applications requiring thermal visualization, such as diagnostic or therapeutic procedures where heat patterns need to be analyzed.

Iskra Medical is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework and market focus, particularly in regions where US-based manufacturers are subject to specific compliance requirements.

Iskra Medical’s devices, including the ISKRA MEDICAL GREEN IRF PRESTIGE, are classified as Class II under regulatory schemes like the FDA’s classification system. This classification typically indicates moderate risk, requiring specific controls to ensure safety and performance without needing the stringent oversight of Class III devices.

Iskra Medical’s devices are listed in the FDA’s 510(k) registry, which is a pre-market submission pathway for demonstrating that a new device is substantially equivalent to a legally marketed predicate device. This pathway is commonly used for Class II devices to demonstrate compliance before commercial distribution.

The Class II classification for Iskra Medical’s devices means they are subject to stricter design controls and manufacturing processes compared to Class I devices, but they do not require the same rigorous clinical trials as Class III devices. This classification helps users and regulators understand the intended use, risk level, and required documentation for safe and effective deployment in clinical settings.